Populene D analogues: Design, concise synthesis and antiproliferative activity

Molecules

Volumn 17, Issue 8, 2012, Pages 9621-9630

  Reddy, Kachi R Kishore Kumar ^a   Longato, Giovanna B ^b   De Carvalho, João E ^b   Ruiz, Ana L T G ^b   Silva, Luiz F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antiproliferative; Cancer; Iodine; Osochromene; Prins cyclization; Pyrans

Indexed keywords

PYRAN DERIVATIVE;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HT29; CHEMISTRY; DRUG EFFECT; HUMAN; IC 50; SYNTHESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; HT29 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; PYRANS;

MLCS; MLOWN;

EID: 84865477924     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17089621     Document Type: Article

References (21)

1. Harvey, A.L. Natural products in drug discovery. Drug Discov. Today 2008, 13, 894-901.
2. Mishra, B.B.; Tiwari, V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem. 2011, 46, 4769-4807.
3. Wang, B.; Deng, J.; Gao, Y.; Zhu, L.; He, R.; Xuet, Y. The screening toolbox of bioactive substances from natural products: A review. Fitoterapia 2011, 82, 1141-1151.
4. Miller, J.S. The Discovery of Medicines from Plants: A Current Biological Perspective. Econ. Bot. 2011, 65, 396-407.
5. Kingston, D.G.I. Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation. J. Nat. Prod. 2011, 74, 496-511.
6. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477.
7. Carter, G.T. Natural products and Pharma 2011: Strategic changes spur new opportunities. Nat. Prod. Rep. 2011, 28, 1783-1789.
8. Wilson, R.M.; Danishefsky, S.J. Applications of total synthesis toward the discovery of clinically useful anticancer agents. Chem. Soc. Rev. 2007, 36, 1207-1226.
9. Kumar, K.; Waldmann, H. Synthesis of Natural Product Inspired Compound Collections. Angew. Chem. Int. Ed. 2009, 48, 3224-3242.
10. Goel, A.; Ram, V.J. Natural and synthetic 2H-pyran-2-ones and their versatility in organic synthesis. Tetrahedron 2009, 65, 7865-7913.
11. Ferreira, V.F.; Ferreira, S.B.; Silva, F.C. Strategies for the synthesis of bioactive pyran naphthoquinones. Org. Biomol. Chem. 2010, 8, 4793-4802.
12. Wright, A.E.; Botelho, J.C.; Guzmán, E.; Harmody, D.; Linley, P.; McCarthy, P.J.; Pitts, T.P.; Pomponi, S.A.; Reed, J.K. Neopeltolide, a macrolide from a lithistid sponge of the family neopeltidae. J. Nat. Prod. 2007, 70, 412-416.
13. Searle, P.A.; Molinski, T.F. Phorboxazoles A and B: Potent cytostatic macrolides from marine sponge Phorbas species. J. Am. Chem. Soc. 1995, 117, 8126-8131.
14. Boonsri, S.; Karalai, C.; Ponglimanont, C.; Chantrapromma, S.; Kanjana-opas, A. Cytotoxic and antibacterial sesquiterpenes from Thespesia populnea. J. Nat. Prod. 2008, 71, 1173-1177.
15. Silva, L.F., Jr.; Quintiliano, S.A.P. An expeditious synthesis of hexahydrobenzo f isochromenes and of hexahydrobenzo f isoquinoline via iodine-catalyzed Prins and aza-Prins cyclization. Tetrahedron Lett. 2009, 50, 2256-2260.
16. Ferraz, H.M.C.; Silva, L.F., Jr. Construction of functionalized indans by thallium(III) promoted ring contraction of 3-alkenols. Tetrahedron 2001, 57, 9939-9949.
17. Schow, S.R.; Bloom, J.D.; Thompson, A.S.; Winzenberg, K.N.; Smith, A.B., III. Milbemycin avermectin studies. 5. Total Synthesis of Milbemmycin BETA-3 and its C(12) Epimer. J. Am. Chem. Soc. 1986, 108, 2662-2674.
18. Ferraz, H.M.C.; Aguilar, A.M.; Silva, L.F., Jr. A diastereoselective total synthesis of the sesquiterpene (±)-mutisianthol. Tetrahedron 2003, 59, 5817-5821.
19. Fouche, G.; Cragg, G.M.; Pillay, P.; Kolesnikova, N.; Maharaj, V.J.; Senabe, J. In vitro anticancer screening of South African plants. J. Ethnopharmacol. 2008, 119, 455-461.
20. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 1991, 83, 757-766.
21. Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer. 2006, 6, 813-823.